Government-funded researchers claim gender-affirming care is more important than having a 'normal' kid.
Pregnant transmen shouldn't be pressured to stop taking testosterone despite the risks it poses to babies, researchers have controversially claimed in a Government-funded study.
Current maternity care guidance for transmen — biological women who identify as the opposite gender — recommends they stop hormone treatment in pregnancy.
The NHS warns it could 'affect the baby's development', with some studies linking exposure to the male sex hormone in the womb to genital abnormalities.
Testosterone is listed as a 'category X' substance in pregnancy in the US because of the dangers it poses to a foetus.
But a panel of experts, including three from Britain, said the current advice centres too heavily on preventing babies from developing birth defects.
Objections against the use of testosterone in pregnancy are too focused on creating 'normal' babies, they argued.
Instead, the team — given a £500,000 grant by a subsidiary of Britain's UK Research and Innovation to conduct research on trans male experiences — suggested NHS guidelines should be shifted to better support trans men to live out their gender identity.
The three British experts were sociologists hailing from the universities of Sheffield, Westminster and Glasgow.
American bioethicists Jennifer Lahl and Kallie Fell called the findings 'insane'.
Writing for the website Reality’s Last Stand, they said: 'Abiding by their paper’s guidance would land us in a vacuum devoid of medical ethics and a seismic shift away from the importance of scientific research and medical evidence in favor of activist directed healthcare.'
(Continue)
Sem comentários:
Enviar um comentário